Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 172 publications
Elevated plasma anandamide levels in sclerotic chronic graft-versus-host disease highlight the endocannabinoid system as a potential therapeutic target.
Journal: Bone marrow transplantation
Published: June 24, 2026
A Comparative Analysis of Skin Responses per 2014 NIH Response Criteria and Modified 2025 NIH Skin Task Force Response Criteria in Patients with Sclerotic Chronic Graft-Versus-Host Disease.
Journal: Transplantation and cellular therapy
Published: May 15, 2026
A Comparative Analysis of Skin Responses per 2014 NIH Response Criteria and Modified 2025 NIH Skin Task Force Response Criteria in Patients With Sclerotic Chronic Graft-Versus-Host Disease.
Journal: Transplantation and cellular therapy
Published: May 15, 2026
Integrating 2D Dermatological Photography with 3D Anatomical Surfaces.
Journal: Proceedings of SPIE--the International Society for Optical Engineering
Published: April 27, 2026
Assessing Open-world Foundation Models for Zero-shot Skin Segmentation in Clinical Dermatological Photographs.
Journal: Proceedings of SPIE--the International Society for Optical Engineering
Published: April 27, 2026
WITHDRAWN: Correction to Chronic graft-versus-host disease. Part II: Disease activity grading and therapeutic management [Journal of the American Academy of Dermatology 2024 Jan;90(1)19-36].
Journal: Journal of the American Academy of Dermatology
Published: February 01, 2026
WITHDRAWN: Correction to Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations [Journal of the American Academy of Dermatology 2024 Jan;90(1)1-16].
Journal: Journal of the American Academy of Dermatology
Published: February 01, 2026
Clinical features, genetics, treatment, and long-term outcomes of STAT3 hyper-IgE syndrome: Single-center cohort analysis.
Journal: The Journal of allergy and clinical immunology
Published: January 25, 2026
Improving U-Net Segmentation of Cutaneous Chronic Graft-Versus-Host Disease in Clinical Photographs with Semi-Supervised Training.
Journal: Proceedings of SPIE--the International Society for Optical Engineering
Published: December 26, 2025
Köhlmeier-Degos disease is an interferonopathy characterized by type I and II interferon-driven inflammatory vasculopathy.
Journal: Cell reports. Medicine
Published: December 03, 2025
Last Updated: 09/26/2026